TG Therapeutics: 4Q Earnings Snapshot

Associated Press
Updated ·1 min read

NEW YORK (AP) _ TG Therapeutics Inc. (TGTX) on Tuesday reported a loss of $88.2 million in its fourth quarter.

On a per-share basis, the New York-based company said it had a loss of 71 cents.

The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 57 cents per share.

The biopharmaceutical company posted revenue of $38,000 in the period, meeting Street forecasts.

For the year, the company reported that its loss widened to $279.4 million, or $2.42 per share. Revenue was nearly unchanged at $152,000.

TG Therapeutics shares have dropped 13% since the beginning of the year. The stock has more than tripled in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TGTX at https://www.zacks.com/ap/TGTX